List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Equine Pharmaceuticals and Supplements Revenue
1.4 Market Analysis by Type
1.4.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Pharmaceuticals
1.4.3 Supplements
1.5 Market by Application
1.5.1 Global Equine Pharmaceuticals and Supplements Market Share by Application: 2022-2027
1.5.2 Thoroughbred Horse
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Equine Pharmaceuticals and Supplements Market
1.8.1 Global Equine Pharmaceuticals and Supplements Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Equine Pharmaceuticals and Supplements Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Equine Pharmaceuticals and Supplements Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Equine Pharmaceuticals and Supplements Sales Volume Market Share by Region (2016-2021)
3.2 Global Equine Pharmaceuticals and Supplements Sales Revenue Market Share by Region (2016-2021)
3.3 North America Equine Pharmaceuticals and Supplements Sales Volume
3.3.1 North America Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.3.2 North America Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Equine Pharmaceuticals and Supplements Sales Volume
3.4.1 East Asia Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.5.1 Europe Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.6.1 South Asia Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.7.1 Southeast Asia Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.8.1 Middle East Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.9.1 Africa Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.10.1 Oceania Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.11.1 South America Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.11.2 South America Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Equine Pharmaceuticals and Supplements Sales Volume (2016-2021)
3.12.1 Rest of the World Equine Pharmaceuticals and Supplements Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Equine Pharmaceuticals and Supplements Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Equine Pharmaceuticals and Supplements Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Equine Pharmaceuticals and Supplements Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Equine Pharmaceuticals and Supplements Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Equine Pharmaceuticals and Supplements Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Equine Pharmaceuticals and Supplements Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Equine Pharmaceuticals and Supplements Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Equine Pharmaceuticals and Supplements Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Equine Pharmaceuticals and Supplements Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Equine Pharmaceuticals and Supplements Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Equine Pharmaceuticals and Supplements Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Equine Pharmaceuticals and Supplements Sales Volume Market Share by Type (2016-2021)
14.2 Global Equine Pharmaceuticals and Supplements Sales Revenue Market Share by Type (2016-2021)
14.3 Global Equine Pharmaceuticals and Supplements Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Equine Pharmaceuticals and Supplements Consumption Volume by Application (2016-2021)
15.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Equine Pharmaceuticals and Supplements Business
16.1 Boehringer Ingelheim
16.1.1 Boehringer Ingelheim Company Profile
16.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Specification
16.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Merck Animal Health
16.2.1 Merck Animal Health Company Profile
16.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Specification
16.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Zoetis
16.3.1 Zoetis Company Profile
16.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Specification
16.3.3 Zoetis Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Bayer Animal Health
16.4.1 Bayer Animal Health Company Profile
16.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Specification
16.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Elanco Animal Health
16.5.1 Elanco Animal Health Company Profile
16.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Specification
16.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Dechra Veterinary Products
16.6.1 Dechra Veterinary Products Company Profile
16.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Specification
16.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 CEVA
16.7.1 CEVA Company Profile
16.7.2 CEVA Equine Pharmaceuticals and Supplements Product Specification
16.7.3 CEVA Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Virbac
16.8.1 Virbac Company Profile
16.8.2 Virbac Equine Pharmaceuticals and Supplements Product Specification
16.8.3 Virbac Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Norbrook Equine
16.9.1 Norbrook Equine Company Profile
16.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Specification
16.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Kyoritsu Seiyaku
16.10.1 Kyoritsu Seiyaku Company Profile
16.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Specification
16.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Vetoquinol
16.11.1 Vetoquinol Company Profile
16.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Specification
16.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Protexin Healthcare
16.12.1 Protexin Healthcare Company Profile
16.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Specification
16.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Audevard
16.13.1 Audevard Company Profile
16.13.2 Audevard Equine Pharmaceuticals and Supplements Product Specification
16.13.3 Audevard Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Ouro Fino Saude
16.14.1 Ouro Fino Saude Company Profile
16.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Specification
16.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Equine Pharmaceuticals and Supplements Manufacturing Cost Analysis
17.1 Equine Pharmaceuticals and Supplements Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
17.4 Equine Pharmaceuticals and Supplements Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Equine Pharmaceuticals and Supplements Distributors List
18.3 Equine Pharmaceuticals and Supplements Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Equine Pharmaceuticals and Supplements (2022-2027)
20.2 Global Forecasted Revenue of Equine Pharmaceuticals and Supplements (2022-2027)
20.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements (2016-2027)
20.4 Global Forecasted Production of Equine Pharmaceuticals and Supplements by Region (2022-2027)
20.4.1 North America Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.3 Europe Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.7 Africa Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.9 South America Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Equine Pharmaceuticals and Supplements Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Equine Pharmaceuticals and Supplements by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.2 East Asia Market Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.3 Europe Market Forecasted Consumption of Equine Pharmaceuticals and Supplements by Countriy
21.4 South Asia Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.5 Southeast Asia Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.6 Middle East Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.7 Africa Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.8 Oceania Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.9 South America Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
21.10 Rest of the world Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
